Skip to content
Business Company News, Finance Investment

Defining the value of ‘doing the right thing’ in business

Monash University 2 mins read

An innovative Australian business tool redefining the way success is measured in mutual enterprises has launched in Europe, putting a price on social good over dollar signs.


The Monash Business School developed the Mutuals Value Measurement framework to help mutual enterprises define their total value, which after results of a
two-year field study in Australia showed overwhelmingly positive results.


Co-creator
Professor Matthew Hall, Professor of Accounting and Associate Dean, Graduate Research, Monash Business School said “Using the Mutuals Value Measurement framework is a way for mutuals and co-operatives to ensure that what is on the table is always something that really matters to members.”


The framework helps co-ops and mutuals to measure their total value creation using six common criteria. These are commerciality, shaping markets, member relationships, community relationships, ecosystem and reciprocity, and mutual mindset.


Being trustworthy and acting in a genuine, trustworthy, authentic and ethical way to ‘doing the right thing’ are other desired behaviours measured using the framework.


Lead researcher,
Dr Paul Thambar of Monash Business School said the study is a successful accounting research project, generating real-world research impacts.


"It highlights how Monash Business School researchers collaborate with industry partners to co-create and deliver value,” Dr Thambar said


Co-ops and mutual enterprises are businesses formed to benefit their members and return value back to members rather than profits to shareholders.


In Australia, this sector generates 7 to 8 per cent of Australia's GDP.


In an economy where ethical business practices are becoming a priority, this original business model used for over a century, is gaining traction as the total and mutual value can be measured and reported.


In Australia, these businesses have diversified into virtually every industry sector including agriculture, housing, manufacturing, retail, banking and finance, and insurance.


It is a similar scenario for businesses in Europe.


However, conventional financial accounting measures do not adequately capture the social purpose and the distinctive value co-operatives and mutuals generate.


Thirteen Australian CMEs participated in the 2018-2019 field study and collaborated with a research team drawn from Monash Business School, Australian National University and Warwick Business School, Coventry, UK.


Melina Morrison, CEO, Business Council of Co-operatives and Mutuals said 

 "Valuing the positive impact of cooperatives and mutuals on their members, their customers, their communities and wider society, is long overdue. It’s a framework that makes sure none of the value co-ops create is hidden, overlooked or ignored.” Ms Morrison said.

 

-Ends - 

Dr Paul Thambar and Professor Matthew Hall are available for interview 


Media Enquiries

Loretta Wylde

Monash University Media and Communications

[email protected]

+61(0) 432 123 106

More from this category

  • Business Company News
  • 17/03/2026
  • 14:48
CPA Australia

Fuel shock and rate hike raises the pressures on businesses and households

17 March 2026 Fuel shock and rate hike raises the pressures on businesses and households CPA Australia warns today’s interest rate rise will deepen…

  • Contains:
  • Business Company News, Human Resources
  • 17/03/2026
  • 11:17
COS (Complete Office Supplies)

Beyond the boardroom: half of Australian employees say old equipment and basics like bathrooms drag down productivity

With national productivity growth under intense policy and boardroom focus, new research suggests a surprising performance lever may lie not in strategy decks, but…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 17/03/2026
  • 10:25
Jane Morgan Management

NeuroScientific Biopharmaceuticals (ASX:NSB) Advances StemSmart(TM) Manufacturing Scale-Up as Phase 2 Crohn’s Disease Trial Preparations Progress

Perth, Australia – 17 March 2026 | NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has reached an important development milestone with the commencement of the first technology transfer manufacturing run of its patented StemSmart™ mesenchymal stem cell (MSC) process at leading Australian cell therapy manufacturer Q-Gen Cell Therapeutics. The initiation of the manufacturing run represents a key step in the transfer of the StemSmart™ manufacturing process to a large-scale clinical contract manufacturer that is then capable of providing adequate supply for Phase 2 clinical trials and future commercialisation. Q-Gen Cell Therapeutics, located within the QIMR Berghofer Medical Research Institute in Brisbane, is one…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.